Binex Co

Binex Co FCF Margin

The Free Cash Flow Margin of Binex Co (053030.KQ) as of Oct 27, 2026 is -27.62 %. In the previous year, Free Cash Flow Margin was -15.98 % — a change of 72.87% (lower).

FCF Margin

-27.62 %

YoY

72.87%

Last updated:

Free Cash Flow Margin of Binex Co is 2025 -27.62 % . Free Cash Flow Margin of Binex Co was 2024 -15.98 % . It decreases by 72.87% lower compared to the previous year.

The Binex Co FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
10.59 KRW
Jan 1, 2019
1.59 KRW
Jan 1, 2020
9.19 KRW
Jan 1, 2021
12.07 KRW
Jan 1, 2022
-12.38 KRW
Jan 1, 2023
-7.99 KRW
Jan 1, 2024
-15.98 KRW
Jan 1, 2025
-27.62 KRW
The Binex Co FCF Margin history
YEARFCF MarginYoY
-27.62 %+72.87%
-15.98 %+99.87%
-7.99 %-35.41%
-12.38 %-202.55%
12.07 %+31.32%
9.19 %+477.37%
1.59 %-84.97%
10.59 %+40.77%
7.52 %-495.19%
-1.90 %-98.18%
-104.57 %+1,651.58%
-5.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Free Cash Flow Margin of Binex Co is -27.62 % in 2025.

Free Cash Flow Margin of Binex Co changed from -15.98 % to -27.62 %, representing a 72.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Binex Co since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Binex Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Binex Co

All Key Metrics — Binex Co